refludan has been researched along with Lupus-Erythematosus--Systemic* in 1 studies
1 other study(ies) available for refludan and Lupus-Erythematosus--Systemic
Article | Year |
---|---|
Extremely low doses of lepirudin in a patient with heparin-induced thrombocytopenia, high bleeding risk and renal insufficiency.
Topics: Anticoagulants; Antiphospholipid Syndrome; Cerebral Hemorrhage; Drug Administration Schedule; Half-Life; Heparin; Hirudins; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Recombinant Proteins; Renal Insufficiency; Thrombocytopenia; Treatment Outcome | 2009 |